Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MS
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/181520 |
Resumo: | Polymyxins are a group of antibacterial substances and have remained the drugs of choice for treatment of resistant Gram-negative bacilli. Polymyxin B is administered by intravenous infusion and requires the reconstitution of lyophilized powder with 0.9% saline or 5% glucose solutions. To date, there is little information about polymyxin stability in different infusions solutions, especially at 40 ºC, a temperature that is recommended to study drug stability as it accelerates degradation reactions. Therefore, in this work an analytical method using LC-MS/MS was developed, validated and applied to determine the stability of polymyxin B diluted in 0.9% saline or 5% glucose solutions at 25 ºC and 40 ºC. The stability of polymyxin B solutions was evaluated during 72 hours. Polymyxin B1 and B2 were stable for 24 hours in saline (0.9%) and glucose solution (5%), however a significant degradation of polymyxin B1 and B2 was observed after 48 hours and 72 hours of assay. The reduction of polymyxin content was evidenced in both saline and glucose media, at room temperature as well as at 40 °C. No significant differences in pH of polymyxin solutions (glucose or saline) were evidenced during stability assay. |
id |
USP-31_253150d38bf0bb58030afcdcad3cbf58 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/181520 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MSPolymyxinStabilityLC-MS/MSGlucose solutionsSaline solutionsPolymyxins are a group of antibacterial substances and have remained the drugs of choice for treatment of resistant Gram-negative bacilli. Polymyxin B is administered by intravenous infusion and requires the reconstitution of lyophilized powder with 0.9% saline or 5% glucose solutions. To date, there is little information about polymyxin stability in different infusions solutions, especially at 40 ºC, a temperature that is recommended to study drug stability as it accelerates degradation reactions. Therefore, in this work an analytical method using LC-MS/MS was developed, validated and applied to determine the stability of polymyxin B diluted in 0.9% saline or 5% glucose solutions at 25 ºC and 40 ºC. The stability of polymyxin B solutions was evaluated during 72 hours. Polymyxin B1 and B2 were stable for 24 hours in saline (0.9%) and glucose solution (5%), however a significant degradation of polymyxin B1 and B2 was observed after 48 hours and 72 hours of assay. The reduction of polymyxin content was evidenced in both saline and glucose media, at room temperature as well as at 40 °C. No significant differences in pH of polymyxin solutions (glucose or saline) were evidenced during stability assay.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2020-12-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/18152010.1590/s2175-97902019000318367Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e18367Brazilian Journal of Pharmaceutical Sciences; v. 56 (2020); e18367Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e183672175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/181520/168538Copyright (c) 2020 Brazilian Journal of Pharmaceutical Scienceshttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessCastilhos, Juliana Kich Dillenburg, Thaís Luise Antunes, Marina Venzon Scribel, Letícia Zavascki, Alexandre Prehn Linden, Rafael Verza, Simone Gasparin 2021-06-12T19:46:54Zoai:revistas.usp.br:article/181520Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2021-06-12T19:46:54Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MS |
title |
Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MS |
spellingShingle |
Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MS Castilhos, Juliana Kich Polymyxin Stability LC-MS/MS Glucose solutions Saline solutions |
title_short |
Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MS |
title_full |
Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MS |
title_fullStr |
Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MS |
title_full_unstemmed |
Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MS |
title_sort |
Evaluation of the stability of Polymyxin B in saline and glucose solutions using LC-MS/MS |
author |
Castilhos, Juliana Kich |
author_facet |
Castilhos, Juliana Kich Dillenburg, Thaís Luise Antunes, Marina Venzon Scribel, Letícia Zavascki, Alexandre Prehn Linden, Rafael Verza, Simone Gasparin |
author_role |
author |
author2 |
Dillenburg, Thaís Luise Antunes, Marina Venzon Scribel, Letícia Zavascki, Alexandre Prehn Linden, Rafael Verza, Simone Gasparin |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Castilhos, Juliana Kich Dillenburg, Thaís Luise Antunes, Marina Venzon Scribel, Letícia Zavascki, Alexandre Prehn Linden, Rafael Verza, Simone Gasparin |
dc.subject.por.fl_str_mv |
Polymyxin Stability LC-MS/MS Glucose solutions Saline solutions |
topic |
Polymyxin Stability LC-MS/MS Glucose solutions Saline solutions |
description |
Polymyxins are a group of antibacterial substances and have remained the drugs of choice for treatment of resistant Gram-negative bacilli. Polymyxin B is administered by intravenous infusion and requires the reconstitution of lyophilized powder with 0.9% saline or 5% glucose solutions. To date, there is little information about polymyxin stability in different infusions solutions, especially at 40 ºC, a temperature that is recommended to study drug stability as it accelerates degradation reactions. Therefore, in this work an analytical method using LC-MS/MS was developed, validated and applied to determine the stability of polymyxin B diluted in 0.9% saline or 5% glucose solutions at 25 ºC and 40 ºC. The stability of polymyxin B solutions was evaluated during 72 hours. Polymyxin B1 and B2 were stable for 24 hours in saline (0.9%) and glucose solution (5%), however a significant degradation of polymyxin B1 and B2 was observed after 48 hours and 72 hours of assay. The reduction of polymyxin content was evidenced in both saline and glucose media, at room temperature as well as at 40 °C. No significant differences in pH of polymyxin solutions (glucose or saline) were evidenced during stability assay. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-12-09 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/181520 10.1590/s2175-97902019000318367 |
url |
https://www.revistas.usp.br/bjps/article/view/181520 |
identifier_str_mv |
10.1590/s2175-97902019000318367 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/181520/168538 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2020 Brazilian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2020 Brazilian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e18367 Brazilian Journal of Pharmaceutical Sciences; v. 56 (2020); e18367 Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e18367 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222915092807680 |